What is BNTC's dilution risk score?

BNTC has a latest available DilutionScore record of 54/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BNTC, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BNTC?

DilutionWatch tracks 25 SEC filing types for BNTC including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BNTC shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BNTC, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BNTC tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BNTC. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BNTC Dilution Risk Score: 54/100 (HIGH)

Score Breakdown

📋 Offering Ability

85

💰 Cash Runway

0

📊 Float Risk

50

⚠️ Warrant Exposure

30

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 23%

💰 Capital Raise model 38%

• Active shelf registration ($100M, 25% of market cap)

• Active ATM program with $100M remaining capacity

📜 Warrant Exercise model 15%

• Warrant overhang: 7.5% of shares outstanding

🔔 Track BNTC — Get forecast alerts →

Market Data

Market Cap$397.14M

Shares Outstanding34.35M

Float17.87M

Cash$184.76M

Debt$876.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 15.1% shares (2026Q1 vs prior)

88 institutional holders · 36.47M shares

#1 SUVRETTA CAPITAL MANAGEMENT, LLC 11.55M shares

#2 JANUS HENDERSON GROUP PLC 5.75M shares

#3 FRANKLIN RESOURCES INC 2.38M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.15M

Days to Cover26.7

% of Float12.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2024-04-22

424B3 ATM 2026-02-11

EFFECT EFFECT 2026-02-10

S-3 SHELF 2026-01-30

4 INSIDER TRANSACTION 2026-01-26

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BNTC Dilution Snapshot

Benitec Biopharma Inc. (BNTC) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $100.0M.
Stored ATM program remaining capacity: $100.0M.
Stored outstanding warrants: 2.6M.
Recent SEC activity tracked for BNTC: 424B3 on 2026-02-11; EFFECT on 2026-02-10; S-3 on 2026-01-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.